Publication | Closed Access

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

AntibioticsClostridium Difficile InfectionAntibiotic AdjuvantRandomised Phase 3PharmacotherapyAntimicrobial ChemotherapyInfection ControlMedicineClinical MicrobiologyAntimicrobial Resistance